-
-
-
-
-
-
-
BTIG Downgrades Theravance Biopharma (TBPH) to Neutral
-
-
-
-
-
-
-
Zymeworks Provides Corporate Update and Reports First Quarter 2026 Financial Results
-
-
-
-
-
-
-
Zymeworks appoints Brian Cherry to board, promotes executives
-
-
-
-
-
-
-
Zymeworks Appoints Scott Platshon as Acting Chief Investment Officer
-
-
-
-
-
-
-
Zymeworks Provides Corporate Update and Reports Second Quarter 2023 Financial Results
-
-
-
-
-
-
-
Zymeworks (ZYME) Adopts Limited-Duration Shareholder Rights Plan, Enables Shareholders to Realize Full Value of Company
-
-
-
-
-
-
-
Atreca Announces Expansion of Preclinical Pipeline
-
1,192,372 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

